Maltose binding site 2 mutations affect product inhibition of Bacillus circulans STB01 cyclodextrin glycosyltransferase
Caiming Li,Yuxian You,Yuzhu Zhang,Xiaofang Xie,Qi Xu,Zhengbiao Gu,Xiaofeng Ban,Xiaoshu Tang,Yan Hong,Li Cheng,Zhaofeng Li
DOI: https://doi.org/10.1016/j.ijbiomac.2021.02.033
IF: 8.2
2021-04-01
International Journal of Biological Macromolecules
Abstract:<p>The efficiency of enzymatic cyclodextrin production using cyclodextrin glycosyltransferases (CGTases) is limited by product inhibition. In this study, maltose binding site 2 (MBS2) of the β-CGTase from <em>Bacillus circulans</em> STB01 was modified to decrease product inhibition. First, two point mutants were prepared at position 599 (A599V and A599N). Then, two double mutants incorporating alanine at position 633 (A599N/Y633A and A599V/Y633A) were prepared. Finally, the entire MBS2 region was replaced by that of the α-CGTase from <em>Paenibacillus macerans</em> JFB05-01 to form multipoint mutant MBS2 β → α. All five mutants exhibited mixed-type product inhibition, although both the competitive and uncompetitive components of this inhibition were decreased. The total cyclization activities of A599N, A599V and A599V/Y633A were 15.6%, 76.8% and 70.9% lower than that of the wild-type, respectively, while that of A599N/Y633A was 22.4% higher. Among the mutants, only MBS2 β → α showed catalytic efficiency (<em>k</em><sub>cat</sub>/<em>K</em><sub>m</sub>) comparable with that of the wild-type. Moreover, A599N, A599N/Y633A and MBS2 β → α produced cyclodextrin yields 13.1%, 15.8% and 19.7% greater than that of the wild-type, respectively. These results suggest that A599N, A599N/Y633A and MBS2 β → α may be more suitable than the wild-type for cyclodextrin production.</p>
polymer science,biochemistry & molecular biology,chemistry, applied